Richard Vosser
Stock Analyst at JP Morgan
(1.67)
# 1,732
Out of 4,479 analysts
7
Total ratings
60%
Success rate
15.21%
Average return
Main Sectors:
Top Industries:
4 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MOR MorphoSys AG | Maintains: Overweight | $10 → $8.5 | $18.10 | -53.04% | 3 | Dec 5, 2023 | |
| MOLN Molecular Partners AG | Maintains: Neutral | $6.6 → $4.5 | $7.00 | -35.71% | 1 | Dec 5, 2023 | |
| NVO Novo Nordisk | Upgrades: Overweight | n/a | $142.98 | - | 2 | Jun 7, 2022 | |
| SNY Sanofi | Upgrades: Overweight | n/a | $48.54 | - | 1 | Jan 6, 2020 |
MorphoSys AG
Dec 5, 2023
Maintains: Overweight
Price Target: $10 → $8.5
Current: $18.10
Upside: -53.04%
Molecular Partners AG
Dec 5, 2023
Maintains: Neutral
Price Target: $6.6 → $4.5
Current: $7.00
Upside: -35.71%
Novo Nordisk
Jun 7, 2022
Upgrades: Overweight
Price Target: n/a
Current: $142.98
Upside: -
Sanofi
Jan 6, 2020
Upgrades: Overweight
Price Target: n/a
Current: $48.54
Upside: -